U.S. Other Utilities Stock News

In recent days, Freedom Capital Markets analyst Ilya Zubkov initiated coverage on IRadimed (IRMD.US) with a buy rating, marking fresh analyst attention on the medical device maker. An interesting wrinkle is that this new positive view comes from an analyst whose prior-year track record shows a success rate of 16.7% and an average return of 21.0% in the wrong direction, which may temper how investors interpret the endorsement. Now we’ll examine how this new, positive analyst coverage might...

Viper Energy recently reported year-over-year revenue growth that outpaced peers and topped analyst expectations, supported by successful integration of newly acquired mineral and royalty assets in the Permian Basin. At the same time, stronger crude and natural gas liquids pricing, together with Viper’s capital‑light royalty model, has amplified the earnings impact of its expanded portfolio. With that backdrop, we’ll now consider how stronger-than-expected revenue performance under higher...

TransUnion (TRU) has rolled out TruIQ Credit Strategy Studio and expanded its relationship with MRI-Simmons, giving lender and advertiser clients new tools to design, test and activate campaigns within unified data and workflow environments. See our latest analysis for TransUnion. These launches and partnerships come as TransUnion’s share price trades at US$69.32, with a 7 day share price return of 5.41% after a weaker 30 day and 90 day stretch. The 3 year total shareholder return of 14.72%...

V2X, Inc. recently appointed Mike Uster as Chief Information Officer, tasking him with leading global IT strategy, cybersecurity, and AI-enabled digital transformation to support the company’s mission-critical defense operations. Uster’s long track record implementing zero-trust architectures and AI-driven capabilities for government and defense clients could materially influence how V2X modernizes its technology backbone for complex contracts worldwide. We’ll now examine how Uster’s...

Why GameStop Matters For Retail Investors Right Now GameStop (GME) has stayed in the spotlight as a specialty retailer focused on games, collectibles and entertainment products, with investors watching how recent share price swings align with its current business footprint. See our latest analysis for GameStop. With the share price at $23.36, GameStop has seen a 2.64% 1 day share price return and a 12.74% 90 day share price return, while the 1 year total shareholder return sits at 0.61%,...

Erie Indemnity (ERIE) is back in focus as investors look ahead to its upcoming fiscal Q1 2026 earnings, following weaker Q4 2025 results and a mixed track record against recent quarterly expectations. See our latest analysis for Erie Indemnity. The upcoming Q1 2026 release comes after a weak Q4 and a clear loss of momentum, with a 90 day share price return decline of 11.5% and a 1 year total shareholder return loss of 36%, even though the stock has bounced 3.6% over the past week to...

Recent analyst commentary around HCA Healthcare (HCA) has centered on its 2026 guidance, connecting executive incentive plans, hospital expansion projects, artificial intelligence tools, and new service lines that some investors view as important potential growth drivers. See our latest analysis for HCA Healthcare. The recent 11.4% 1 month share price decline to around $471.84 comes after a strong 1 year total shareholder return of 43.2%. This suggests shorter term momentum has cooled even as...

In March 2026, Element Solutions Inc. reported that Executive Chairman Sir Martin E. Franklin would step down and not seek re-election at the 2026 Annual Meeting, with long-time director Ian G.H. Ashken set to become Non-Executive Chairman. Around the same time, high-profile commentary from Jim Cramer spotlighted Element Solutions’ growth outlook and valuation in specialty chemicals, bringing renewed attention to its role in advanced electronics and semiconductor markets. With Jim Cramer...

T. Rowe Price Group (TROW) has appointed Bill Cashel as Head of Alternatives for U.S. Wealth, a move focused on expanding its alternative and private market offering for retirement and wealth investors. See our latest analysis for T. Rowe Price Group. The appointment of a dedicated alternatives head comes as T. Rowe Price Group’s share price has eased in recent months, with a 90-day share price return of a 15.33% decline and a year-to-date share price return of a 13.82% decline, while the...

In recent weeks, BKV Corporation has drawn fresh attention as Jim Cramer highlighted its natural gas, power generation and carbon capture businesses against a backdrop of shifting Middle East geopolitics and rising focus on U.S. LNG exports. At the same time, revised analyst earnings expectations and BKV’s push to lock in long-term power contracts at its Temple Energy Complex underscore how investor debate is increasingly centered on the durability and visibility of its future cash...

In late March and early April 2026, Applied Optoelectronics Inc. announced that a major hyperscale customer expanded its 800G single‑mode data center transceiver orders to US$124 million, while earlier also securing an over US$200 million volume order for 1.6T modules and beginning initial 800G shipments to a second hyperscale client. Together, these large AI‑oriented transceiver commitments significantly increase Applied Optoelectronics’ backlog and highlight how its vertically integrated...

Spyre Therapeutics (SYRE) recently accelerated its Phase 2 SKYWAY basket trial by completing enrollment for the rheumatoid arthritis sub study of SPY072 ahead of schedule, with topline data now guided for Q3 2026. See our latest analysis for Spyre Therapeutics. The accelerated SKYWAY timeline comes on top of a sharp run, with Spyre Therapeutics posting a 30 day share price return of 18.51% and a 90 day share price return of 58.81%. The 1 year total shareholder return of 272.01% and 3 year...

AZZ (AZZ) is back on investors’ radar after better than expected Q3 2026 earnings and revenue, fresh fiscal 2027 guidance, a new US$100 million buyback plan, and recent institutional buying interest. See our latest analysis for AZZ. AZZ’s share price has climbed 13.87% over the past 90 days and its 1 year total shareholder return of 65.39% and 3 year total shareholder return above 200% point to strong momentum around recent earnings beats, fiscal 2027 guidance, buybacks, and fresh...

FuboTV (NYSE:FUBO) approved a reverse stock split and amended its bylaws to reflect the change. The reverse split has already been implemented, consolidating existing shares into a smaller number. These actions adjust the company’s share structure and may influence its exchange listing status and future financing options. FuboTV operates a live TV streaming platform focused on sports, news, and entertainment, positioning itself as an alternative to traditional cable bundles. The reverse...

Green Brick Partners, Inc. and HFI Capital Management, LLC have launched Rainwater Crossing, a master-planned community in Celina, Texas, with Phase One builders Normandy Homes and Centre Living Homes, extensive amenities, and public art, following its spring 2026 debut plan. The emphasis on art-driven placemaking and a broad amenity mix, including over six miles of trails and multiple future amenity sites, highlights Green Brick’s focus on lifestyle communities that could influence how...

Power Solutions International (PSIX) is in the spotlight after multiple securities class action lawsuits questioned its disclosures around data center power generation, production ramp up challenges, and gross margin pressure tied to recent operational decisions. See our latest analysis for Power Solutions International. Despite the legal headlines and margin concerns, Power Solutions International's share price has climbed to US$67.55, with a 1 month share price return of 29.53% and a 1 year...

Universal Corporation recently reported past third-quarter revenue of US$861.3 million, below the prior year’s level, while also announcing the appointment of Anubhav Mittal as Senior Vice President and Chief Financial Officer, effective February 17, 2026. Despite a tobacco oversupply, management emphasized firm customer demand and smooth shipments in the tobacco segment, suggesting operational resilience amid challenging market conditions. With Universal’s revenue miss and incoming CFO now...

In March 2026, a federal antitrust class action was filed against Vail Resorts and Alterra Mountain Company, alleging that their Epic and Ikon ski pass bundles and high single-day lift-ticket prices unlawfully suppress competition and inflate costs for skiers and snowboarders across North America. The lawsuit argues that the two companies’ control over access to nearly all marquee destination ski resorts has left consumers with limited alternatives and pressured independent regional...

RLI (RLI) has reshaped its Claims leadership by promoting Cory Figiel to Chief Claim Officer and Charles Spiekerman to Vice President of Claim, following the retirement of long-serving executive Bob Handzel. See our latest analysis for RLI. Leadership changes in the Claim organization come as the share price trades at US$58.14, with a 1 day share price return of 2.11% and a 1 year total shareholder return decline of 21%, suggesting recent momentum has softened after a stronger five year total...

Sun Cruiser White Tea + Vodka launch puts Boston Beer Company (SAM) in focus Boston Beer Company (SAM) is back on investor radars after its Sun Cruiser brand introduced White Tea + Vodka, a non carbonated ready to drink line that is positioned around lighter calories and sugar. See our latest analysis for Boston Beer Company. The new Sun Cruiser line lands at a time when momentum in Boston Beer Company’s share price has picked up, with a 21.71% 90 day share price return and a 20.51% year to...

Resideo Technologies earnings spark fresh look at the stock Resideo Technologies (REZI) has moved back into focus after its latest earnings announcement, where the company issued robust 2025 guidance and reported that it exceeded its Q4 2025 financial outlook, drawing fresh attention from investors. See our latest analysis for Resideo Technologies. The earnings update appears to have helped shift sentiment, with a 7 day share price return of 3.99% and a 1 year total shareholder return of...

Ocular Therapeutix recently announced that it will present additional data and analyses from its Phase 3 SOL-1 superiority trial of AXPAXLI for wet age-related macular degeneration at multiple scientific conferences in April 2026, highlighting durability, efficacy, and safety outcomes. These upcoming scientific presentations are set to put AXPAXLI’s clinical profile under closer scrutiny from physicians and researchers, potentially sharpening how the therapy is perceived within the...

Why Jabil (JBL) Is On Investors’ Radar Today Jabil (JBL) has drawn fresh attention after recent trading, with the stock last closing at $268.55. Investors are weighing this price against its recent performance and the company’s current fundamentals. See our latest analysis for Jabil. Although the share price slipped 1.25% over the last trading day, Jabil’s 11.39% 1 month share price return and very strong 1 year total shareholder return of 130.12% suggest that momentum has been building over...

GeneDx Holdings (WGS) recently drew attention after a 21% share price drop, as bearish technical signals, mixed analyst views, and institutional fund outflows contrasted with a more upbeat stance from some retail investors. See our latest analysis for GeneDx Holdings. Short term momentum has been volatile, with a 1 day share price return of 1.04% and a 7 day gain of 15.96%, following a 30 day share price decline of 24.87% and a year to date share price return of 49.96% in the red. The 3 year...